Skip to search formSkip to main contentSkip to account menu

KD3010

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Abstract 3921: KD3010, a PPAR{beta}/{delta} Selective Small Molecule Agonist, Improves Hyperglycemia And Insulin Resistance while alleviating Rosiglitazone-Induced Side Effects in Murine Models
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)